The researchers also confirmed that acetylation of H3K27 was inhibited and speculated that the development of gemcitabine resistance in pancreatic cancer was prevented, at least in part, by a HAT-dependent mechanism [83]. This evidence concerns the gene TMPRSS11D and familial pancreatic carcinoma.